BSB
NVO

Bangor Savings Bank’s Novo Nordisk NVO Stock Holding History

Bangor Savings Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
24,846
-71
-0.3% -$3.05K 0.09% 96
2026
Q1 		$916K Sell
24,917
-599
-2% -$28.4K 0.07% 106
2025
Q4 		$1.3M Sell
25,516
-2,455
-9% -$126K 0.1% 87
2025
Q3 		$1.55M Buy
27,971
+10,969
+65% +$642K 0.13% 78
2025
Q2 		$1.17M Buy
17,002
+22
+0.1% +$1.5K 0.1% 96
2025
Q1 		$1.18M Buy
16,980
+243
+1% +$20.1K 0.11% 94
2024
Q4 		$1.44M Sell
16,737
-544
-3% -$58.8K 0.14% 86
2024
Q3 		$2.06M Sell
17,281
-285
-2% -$38K 0.19% 61
2024
Q2 		$2.51M Sell
17,566
-312
-2% -$41.3K 0.25% 47
2024
Q1 		$2.3M Sell
17,878
-642
-3% -$76.4K 0.23% 59
2023
Q4 		$1.92M Sell
18,520
-194
-1% -$19.2K 0.21% 69
2023
Q3 		$1.7M Buy
18,714
+164
+0.9% +$14.4K 0.2% 69
2023
Q2 		$1.5M Buy
18,550
+606
+3% +$49.5K 0.17% 80
2023
Q1 		$1.43M Sell
17,944
-11,078
-38% -$786K 0.17% 84
2022
Q4 		$1.96M Buy
29,022
+4,732
+19% +$277K 0.23% 58
2022
Q3 		$1.21M Buy
24,290
+158
+0.7% +$8.46K 0.14% 99
2022
Q2 		$1.34M Buy
24,132
+190
+0.8% +$10.5K 0.15% 94
2022
Q1 		$1.33M Buy
23,942
+1,798
+8% +$92.3K 0.14% 94
2021
Q4 		$1.24M Buy
22,144
+1,300
+6% +$70.4K 0.12% 109
2021
Q3 		$1M Buy
20,844
+4,518
+28% +$218K 0.1% 113
2021
Q2 		$684K Buy
16,326
+1,714
+12% +$66.4K 0.08% 129
2021
Q1 		$492K Buy
14,612
+206
+1% +$7.34K 0.06% 143
2020
Q4 		$503K Sell
14,406
-2,296
-14% -$79.4K 0.07% 136
2020
Q3 		$580K Buy
16,702
+1,772
+12% +$59.1K 0.09% 115
2020
Q2 		$489K Sell
14,930
-612
-4% -$19.5K 0.08% 122
2020
Q1 		$468K Sell
15,542
-276
-2% -$8.22K 0.09% 115
2019
Q4 		$458K Buy
15,818
+2,188
+16% +$60.6K 0.07% 124
2019
Q3 		$353K Sell
13,630
-666
-5% -$16.8K 0.06% 141
2019
Q2 		$364K Buy
14,296
+72
+0.5% +$1.78K 0.06% 134
2019
Q1 		$372K Buy
14,224
+666
+5% +$16.4K 0.07% 130
2018
Q4 		$312K Buy
13,558
+162
+1% +$3.6K 0.06% 136
2018
Q3 		$316K Buy
13,396
+214
+2% +$5.22K 0.06% 147
2018
Q2 		$303K Sell
13,182
-358
-3% -$8.51K 0.06% 146
2018
Q1 		$334K Buy
13,540
+478
+4% +$12.6K 0.07% 136
2017
Q4 		$351K Buy
13,062
+700
+6% +$17.8K 0.07% 135
2017
Q3 		$298K Buy
12,362
+940
+8% +$21.2K 0.06% 137
2017
Q2 		$245K Buy
+11,422
New +$230K 0.05% 129
2016
Q4 		– Sell
-49,522
Closed -$1.03M – 140
2016
Q3 		$1.03M Sell
49,522
-508
-1% -$12.6K 0.25% 73
2016
Q2 		$1.34M Sell
50,030
-1,848
-4% -$50.7K 0.33% 62
2016
Q1 		$1.41M Buy
51,878
+36
+0.1% +$964 0.35% 57
2015
Q4 		$1.5M Buy
51,842
+148
+0.3% +$4.1K 0.38% 53
2015
Q3 		$1.4M Buy
51,694
+728
+1% +$20.6K 0.36% 54
2015
Q2 		$1.4M Sell
50,966
-8,872
-15% -$249K 0.34% 59
2015
Q1 		$1.6M Buy
59,838
+4,142
+7% +$95.4K 0.38% 52
2014
Q4 		$1.18M Sell
55,696
-160
-0.3% -$3.57K 0.3% 66
2014
Q3 		$1.33M Buy
55,856
+154
+0.3% +$3.54K 0.36% 59
2014
Q2 		$1.29M Sell
55,702
-1,182
-2% -$26.1K 0.34% 63
2014
Q1 		$1.3M Buy
+56,884
New +$1.21M 0.39% 50

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Bangor Savings Bank's NVO Position: Q2 2026 in Review

Bangor Savings Bank reduced its Novo Nordisk (NVO) stake by 0.28% in Q2 2026, selling an estimated $3.05K and leaving 24,846 shares worth $1.19M. The position accounts for 0.09% of the portfolio, ranked #96.

Bangor Savings Bank first reported a position in NVO in Q1 2014 and has held it in 48 quarters since. The position peaked at $2.51M in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bangor Savings Bank held 24,846 shares of Novo Nordisk worth $1.19M as of Q2 2026.
  • Bangor Savings Bank sold 71 Novo Nordisk shares in Q2 2026, an estimated $3.05K.
  • Novo Nordisk made up 0.09% of Bangor Savings Bank's portfolio in Q2 2026, its #96 holding.
  • Bangor Savings Bank first reported a position in Novo Nordisk in Q1 2014 and has held it in 48 quarters since.
  • Bangor Savings Bank's Novo Nordisk position peaked at $2.51M in Q2 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.